了解青光眼:为什么它仍然是全球失明的主要原因。

IF 0.7 4区 医学 Q4 OPHTHALMOLOGY
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-01 Epub Date: 2025-07-24 DOI:10.1055/a-2617-1575
Tienan Qi, Hanhan Liu, Layla Frühn, Katrin Löw, Claus Cursiefen, Verena Prokosch
{"title":"了解青光眼:为什么它仍然是全球失明的主要原因。","authors":"Tienan Qi, Hanhan Liu, Layla Frühn, Katrin Löw, Claus Cursiefen, Verena Prokosch","doi":"10.1055/a-2617-1575","DOIUrl":null,"url":null,"abstract":"<p><p>Glaucoma is one of the leading causes of irreversible blindness worldwide and is often referred to as the \"silent thief of sight\", because it often progresses without noticeable symptoms until significant vision loss occurs. With an estimated 76 million patients affected in 2020 and a forecast of over 111 million by 2040, the global situation requires urgent attention. Vision loss caused by glaucoma is irreversible but largely preventable, highlighting the importance of early detection and treatment. Diagnosis presents significant challenges, particularly due to the asymptomatic nature of the disease and age-related risk factors. Inequalities in care and access to appropriate treatments are other barriers leading to delayed diagnoses. Early diagnosis and interventions are critical to slow disease progression, protect remaining vision and improve the quality of life of those affected. These measures are particularly important to minimise the psychological impact and impairment in daily activities. The use of innovative technologies and targeted interventions could help improve the early detection and treatment of glaucoma and thus reduce the risk of irreversible vision loss.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":"242 7","pages":"712-717"},"PeriodicalIF":0.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12302165/pdf/","citationCount":"0","resultStr":"{\"title\":\"Understanding Glaucoma: Why it Remains a Leading Cause of Blindness Worldwide.\",\"authors\":\"Tienan Qi, Hanhan Liu, Layla Frühn, Katrin Löw, Claus Cursiefen, Verena Prokosch\",\"doi\":\"10.1055/a-2617-1575\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Glaucoma is one of the leading causes of irreversible blindness worldwide and is often referred to as the \\\"silent thief of sight\\\", because it often progresses without noticeable symptoms until significant vision loss occurs. With an estimated 76 million patients affected in 2020 and a forecast of over 111 million by 2040, the global situation requires urgent attention. Vision loss caused by glaucoma is irreversible but largely preventable, highlighting the importance of early detection and treatment. Diagnosis presents significant challenges, particularly due to the asymptomatic nature of the disease and age-related risk factors. Inequalities in care and access to appropriate treatments are other barriers leading to delayed diagnoses. Early diagnosis and interventions are critical to slow disease progression, protect remaining vision and improve the quality of life of those affected. These measures are particularly important to minimise the psychological impact and impairment in daily activities. The use of innovative technologies and targeted interventions could help improve the early detection and treatment of glaucoma and thus reduce the risk of irreversible vision loss.</p>\",\"PeriodicalId\":17904,\"journal\":{\"name\":\"Klinische Monatsblatter fur Augenheilkunde\",\"volume\":\"242 7\",\"pages\":\"712-717\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12302165/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinische Monatsblatter fur Augenheilkunde\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2617-1575\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinische Monatsblatter fur Augenheilkunde","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2617-1575","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

青光眼是世界范围内不可逆失明的主要原因之一,通常被称为“无声的视力窃贼”,因为它通常在没有明显症状的情况下发展,直到发生明显的视力丧失。2020年估计有7600万患者受到影响,预计到2040年将超过1.11亿人,因此全球形势需要紧急关注。青光眼造成的视力丧失是不可逆转的,但在很大程度上是可以预防的,这突出了早期发现和治疗的重要性。诊断提出了重大挑战,特别是由于疾病的无症状性质和与年龄相关的危险因素。护理和获得适当治疗方面的不平等是导致延误诊断的其他障碍。早期诊断和干预对于减缓疾病进展、保护剩余视力和改善受影响者的生活质量至关重要。这些措施对于尽量减少日常活动中的心理影响和损害尤为重要。使用创新技术和有针对性的干预措施可以帮助改善青光眼的早期发现和治疗,从而降低不可逆视力丧失的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Understanding Glaucoma: Why it Remains a Leading Cause of Blindness Worldwide.

Glaucoma is one of the leading causes of irreversible blindness worldwide and is often referred to as the "silent thief of sight", because it often progresses without noticeable symptoms until significant vision loss occurs. With an estimated 76 million patients affected in 2020 and a forecast of over 111 million by 2040, the global situation requires urgent attention. Vision loss caused by glaucoma is irreversible but largely preventable, highlighting the importance of early detection and treatment. Diagnosis presents significant challenges, particularly due to the asymptomatic nature of the disease and age-related risk factors. Inequalities in care and access to appropriate treatments are other barriers leading to delayed diagnoses. Early diagnosis and interventions are critical to slow disease progression, protect remaining vision and improve the quality of life of those affected. These measures are particularly important to minimise the psychological impact and impairment in daily activities. The use of innovative technologies and targeted interventions could help improve the early detection and treatment of glaucoma and thus reduce the risk of irreversible vision loss.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.30
自引率
0.00%
发文量
235
审稿时长
4-8 weeks
期刊介绍: -Konzentriertes Fachwissen aus Klinik und Praxis: Die entscheidenden Ergebnisse der internationalen Forschung - für Sie auf den Punkt gebracht und kritisch kommentiert, Übersichtsarbeiten zu den maßgeblichen Themen der täglichen Praxis, Top informiert - breite klinische Berichterstattung. -CME-Punkte sammeln mit dem Refresher: Effiziente, CME-zertifizierte Fortbildung, mit dem Refresher, 3 CME-Punkte pro Ausgabe - bis zu 36 CME-Punkte im Jahr!. -Aktuelle Rubriken mit echtem Nutzwert: Kurzreferate zu den wichtigsten Artikeln internationaler Zeitschriften, Schwerpunktthema in jedem Heft: Ausführliche Übersichtsarbeiten zu den wichtigsten Themen der Ophthalmologie – so behalten Sie das gesamte Fach im Blick!, Originalien mit den neuesten Entwicklungen, Übersichten zu den relevanten Themen.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信